USX:SURF - Surface Oncology, Inc Surface Oncology, Inc
Sector: Health Care, Industry: Biotechnology
Next Earnings: 9 Aug 2021
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 7.52    -0.100 (-1.31%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

11 Jun 2021


Loading...
Loading...
Loading...

General

CEO: Dr. Robert W. Ross

IPO: 2018-04-19

Headquarters: US

Employees: 51

Homepage

Description

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses. The company's pipeline products are SRF231, SRF373, SRF617, and SRF388. Geographically, the activities are carried out through the region of the United States.